The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Degnan Chris since 2018.
This trader's CIK number is 1741968.
At the time of last reporting, Degnan Chris was the Chief Financial Officer of Galera Therapeutics, Inc.. (stock ticker symbol GRTX).
Also see all insider trading activities at Galera Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | GRTX | 10,000 | $19,590 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | VRCA | 3,000 | $45,000 | 0 | $0 | 0 | $0 |
1. Galera Therapeutics, Inc. (GRTX)
2. Verrica Pharmaceuticals Inc. (VRCA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-13 | GRTX | Buy | 10,000 | 1.96 | 19,590 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-06-19 | VRCA | Buy | 3,000 | 15.00 | 45,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Degnan Chris (Chief Financial Officer of Galera Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.